This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Marsh & McLennan's (MMC) Unit Closes Pavilion Acquisition
by Zacks Equity Research
Marsh & McLennan's (MMC) arm wraps up the pending purchase of Pavilion to enrich customer experiences.
Aon Issues Unsecured Notes, Gets Rating Actions From Moody's
by Zacks Equity Research
Aon (AON) issued senior unsecured notes get rating affirmations from Moody's. Outlook remains stable.
Arthur J. Gallagher Buyout to Brace Central California Base
by Zacks Equity Research
Arthur J. Gallagher (AJG) steadily ramps up its inorganic growth profile, this time with Buckman-Mitchell buyout.
Arthur J. Gallagher's Buyout to Fortify California Footprint
by Zacks Equity Research
Arthur J. Gallagher (AJG) consistently boosts its inorganic growth profile, this time with R.T. Beers & Company buyout.
6 Solid Reasons to Hold Aon (AON) Stock in Your Portfolio
by Zacks Equity Research
Banking on solid results, strategic initiatives and a strong financial position, Aon (AON) promises to reap favorable returns for investors.
Marsh & McLennan Unit Buyout to Offer Better Client Services
by Zacks Equity Research
Marsh & McLennan's (MMC) arm Mercer wraps up the acquisition of Summit Strategies Group to boost customer relations.
Arthur J. Gallagher Boosts Professional Liability Coverages
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of JP Tech Insurance Services will help it solidify its portfolio of coverages to better serve clients.
Brown & Brown Enhances Employee Benefits With Hays Buyout
by Zacks Equity Research
Brown & Brown's (BRO) Hays Companies buyout will help consolidate its Midwest footprint, ramp up organic growth and expand capabilities.
Marsh & McLennan's Arm Sets Up Digital Broker Platform
by Zacks Equity Research
Marsh & McLennan's (MMC) unit unveils a cloud-based digital broker platform called Bluestream.
Marsh & McLennan (MMC) to Launch Specialty Business
by Zacks Equity Research
Marsh & McLennan (MMC) to launch a new specialty business named Marsh-JLT Specialty. The same is pending closure of the Jardine Lloyd Thompson Group's acquisition.
Marsh & McLennan (MMC) Hits 52-Week High on Solid Q3 Results
by Zacks Equity Research
Shares of Marsh & McLennan (MMC) scale a 52-week high on Nov 9, backed by a solid third-quarter earnings performance.
EHealth (EHTH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 8th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th
EHealth (EHTH) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher Expands in Hispanic Market With Pronto
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Pronto to help it consolidate its position as one of the largest MGAs in the country and enhance its Risk Placement Services' offerings.
Can The Uptrend Continue for eHealth (EHTH)?
by Zacks Equity Research
Investors certainly have to be happy with eHealth, Inc. (EHTH) and its short term performance
eHealth (EHTH) Q4 Loss Narrower Than Expected, View Revised
by Zacks Equity Research
eHealth???s (EHTH) Q4 reflects soft performance at Individual, Family and Small Business segment and higher costs weighing on the stock.
eHealth (EHTH) Expects to Incur Net Loss in Q4, Shares Down
by Zacks Equity Research
eHealth's (EHTH) submitted applications for all its Medicare products increased 10% year over year in 2017 but failed to meet management's growth expectation in high-teens.
Avoid These Stocks at Highs While Earnings Plummet
by David Bartosiak
These five stocks are near 52-week highs while they have experienced negative earnings estimate revisions
eHealth to Provide Square's Clients With Insurance Solutions
by Zacks Equity Research
eHealth collaborates with Square to provide health insurance solutions to the payment vendor's clients and customers.
eHealth (EHTH) Q2 Loss Wider Than Expected, '17 View Intact
by Zacks Equity Research
eHealth's (EHTH) second-quarter results reflect lower revenues, higher expenses and lower memberships.
Arthur J. Gallagher & Co. Ramps Up Expansion with Buyouts
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) has announced to take over Armstrong/Robitaille/Riegle, Inc., and Ann Arbor Business Advisors, LLC. in Michigan and Total Reward Group in England.
Arthur J. Gallagher Buys Williams-Manny Insurance Group
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) recently acquired Williams-Manny Insurance Group to add capabilities to its compelling portfolio.
Why You Should Hold Willis Towers (WLTW) Stock for Now
by Zacks Equity Research
Shares of Willis Towers Watson plc (WLTW) have outperformed the Zacks categorized Insurance Brokerage industry, year to date. The estimates have also been revised upward over the last 30 days.
Why Should You Retain Arthur J. Gallagher (AJG) In Portfolio?
by Zacks Equity Research
We believe Arthur J. Gallagher's (AJG) solid organic and inorganic background, strong balance sheet and effective capital deployment bodes well for long-term growth.